This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Long, R.
Right arrow Articles by Light, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Long, R.
Right arrow Articles by Light, B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2005, p. 1209-1212, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1209-1212.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Inhaled Nitric Oxide Treatment of Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears

Richard Long,1* Richard Jones,1 James Talbot,2 Irvin Mayers,1 James Barrie,3 Michael Hoskinson,3 and Bruce Light4

Departments of Medicine,1 Medical Microbiology and Immunology,2 Radiology, University of Alberta, Edmonton,3 the Department of Medicine, University of Manitoba, Winnipeg, Canada4

Received 11 August 2004/ Returned for modification 7 October 2004/ Accepted 21 October 2004

Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but does not accelerate airway disinfection.


* Corresponding author. Mailing address: Department of Medicine, University of Alberta, Room 8325, Aberhart Centre 1, 11402, University Ave., Edmonton, Alberta T6G 2J3, Canada. Phone: (780) 407-1427. Fax: (780) 407-1429. E-mail: richard.long{at}ualberta.ca.


Antimicrobial Agents and Chemotherapy, March 2005, p. 1209-1212, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1209-1212.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mannick, J. B. (2006). Immunoregulatory and antimicrobial effects of nitrogen oxides.. Proc Am Thorac Soc 3: 161-165 [Abstract] [Full Text]